The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder

Current Medical Research and Opinion

Volumn 26, Issue 8, 2010, Pages 1843-1853

  Asche, Carl V ^a   Joish, Vijay N ^b   Camacho, Fabian ^c   Drake, Christopher L ^d,e  

^a UNIVERSITY OF UTAH   (United States)

^b SANOFI   (France)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e Wayne State College of Medicine   (United States)

Author keywords

Burden of illness; Cost; Depression; Economics; Insomnia; Major depressive disorder; Managed care; Sleep disorders

Indexed keywords

ESTAZOLAM; ESZOPICLONE; FLURAZEPAM; QUAZEPAM; RAMELTEON; TEMAZEPAM; TRAZODONE; TRIAZOLAM; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DRUG RELEASE; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HOSPITAL PATIENT; HUMAN; INSOMNIA; INTERNATIONAL CLASSIFICATION OF DISEASES; LINEAR REGRESSION ANALYSIS; LOG RANK TEST; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANAGED CARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVATIONAL METHOD; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT SELECTION; PRESCRIPTION; RETROSPECTIVE STUDY; SAMPLING; SENSITIVITY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; COST OF ILLNESS; DATABASES, FACTUAL; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTH EXPENDITURES; HUMANS; INSURANCE CLAIM REVIEW; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; UNITED STATES;

EID: 77954727282     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.488037     Document Type: Article

References (30)

1. Edinger JD, Means MK, Carney CE, et al. Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia. Sleep. 2008 May 1;31:591-2.
2. Martin SA, Aikens JE, Chervin RD. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med Rev 2004;8:63-72
3. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22(Suppl. 2):S386-93
4. Stoller MK. Economic effects of insomnia. Clin Ther 1994;16:873-97; discussion 854
5. NIH State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults statement. J Clin Sleep Med 2005;1:412-21
6. Buysse DJ, Reynolds 3rd CF, Kupfer DJ, et al. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICDS), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep 1994;17:630-7
7. National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005;28:1049-57
8. Ford DE, Kamerow DB, Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262: 1479-84
9. Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007;30:263-73
10. Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999;22(Suppl.2):S394-401
11. Johnson LC, Spinweber CL. Good and poor sleepers differ in Navy performance. Mil Med 1983;148:727-31
12. Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia. An overview. Pharmacoeconomics 1996;10(Suppl. 1):1-14
13. Godet-Cayre V, Pelletier-Fleury N, Le Vaillant M, et al. Insomnia and absenteeism at work. Who pays the cost? Sleep 2006;29:179-84
14. Hillman DR, Murphy AS, Pezzullo L. The economic cost of sleep disorders. Sleep 2006;29:299-305
15. Daley MD, Morin CM, LeBlance, et al. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep. 2009;32:55-64
16. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-5
17. Manber R, Edinger JD, Gress JL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008;31:489
18. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluox-etine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatr 2006;59:1052-60
19. Walsh JK, Erman M, Erwin CW, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharmacol Clin Exp 1998;13:191-8
20. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal depressed non-insomniacs and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:249-60
21. Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 1999;60(Suppl. 17):28-31
22. Morlock RJ, Tan M, Mitchell DY. Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of the National Ambulatory Medical Survey data, 1997-2002. Clin Ther 2006;28:1044-53
23. Roehrs T, Roth T. 'Hypnotic' prescription patterns in a large managed-care population. Sleep Med 2004;5:463-6
24. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
25. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
26. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol 1996;49:1429-33
27. Ashcraft ML, Fries BE, Nerenz DR, et al. A psychiatric patient classification system. An alternative to diagnosis-related groups. Med Care 1989 May;27:543-57
28. Fitzmaurice GM, Laird NM, Ware JW. Applied Longitudinal Modeling. Hoboken, NJ: John Wiley & Sons, 2004: 291-321
29. Ozminkowski RJ, Wang S, Walsh JK, The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007;30:263-73
30. Simon G, Ormel J, VonKorff M, et al. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995; 152:352-7